Log in

New Hampshire Alcohol & Drug Abuse Counselors Association

Dedicated to Advancing Addiction Professionals in New Hampshire


For NH job postings please complete the NHADACA Job Posting Request Form to advertise a vacant job opportunity for others to see. Once we receive the completed form, we will post it to our website within 10 business days. We will display your substance use related job post for 30 days. If you have any questions, please contact us by emailing

  • March 18, 2020 11:39 AM | Anonymous

    Dear NHADACA / NHTIAD Community,

    All NHADACA trainings and events through the end of April will be converted to remote attendance via Zoom or cancelled.  In the next few weeks, we will evaluate doing the same for May and June.  We are working diligently to consult presenters on the applicability of their training to an online format, update the website, notify registrants, and process credits & refunds.  We are doing our best to respond to your health and credentialing needs, and as soon as possible we will also start working from home ourselves.  We will still have access to emails and phone messages, but it may take slightly longer to get back to you (at least initially).  Please check our website for trainings that are cancelled, but remember we are still working on March & April and will update May and June as soon as we can.

    Most sincerely yours,

    Dianne Pepin Castrucci, MLADC

  • March 17, 2020 3:55 PM | Anonymous

    Effective Immediately, and for a period of 30 days from today, ALL TESTING SERVICES ARE HALTED throughout the United States and Canada.

    Within the past 24 hours, the US Centers for Disease Control (CDC) have issued updated guidance on measures to be taken to reduce the spread of the COVID-19 disease.  In particular, the CDC lowered the number of people that should be able to congregate in the same space from 50 to 10 in the United States. 

    Given this new guidance, Prometric has determined it is necessary and appropriate to close our test centers in the United States and Canada for a period of 30 days, starting today on March 17.  This dramatic step is necessary in order to comply with this new federal guidance as well as to further protect the health and well-being of the individual test takers and the staff that provide services at each of our testing locations.  We anticipate re-opening our test centers effective April 16, however, please note that the specific date will be dependent on circumstances that are changing daily.

    Operations teams are actively reaching out to individuals with testing appointments today and throughout the closure period, in an effort to prevent them from unnecessarily appearing at the testing centers.  We will be taking measures to reschedule those impacted appointments into a new date after the planned re-opening and will be communicating that information to the impacted individuals.  We will work closely with the test takers to find new appointment dates and times that work for their schedules, and we will be waiving any rescheduling fees.

  • March 14, 2020 1:54 PM | Anonymous

    HIPAA Rules During the Coronavirus - COVID-19 - Outbreak

    The HIPAA Privacy Rule and OCR guidance clearly explain how Covered Entities and their Business Associates may collaborate and communicate with other Covered Entities and Public Health Authorities during the COVID-19 outbreak, and how to communicate with family, friends and others involved in the patient’s care.

    Date: Wednesday April 1, 2020
    Time: 10:00 AM PDT | 01:00 PM EDT
    Duration: 60 Minutes
    Instructor: Maggie Hales


    A widespread infectious disease outbreak like COVID-19 stresses the health care system.

    HIPAA Rules regarding protected health information (PHI) are not suspended, but key provisions in the Privacy Rule manage the permitted and required uses and disclosures of PHI. And, if there is a Presidential Declaration of a Public Health Emergency, the Secretary of the U.S. Department of Health and Human Services can temporarily waive some HIPAA requirements.

    The HIPAA Privacy Rule and OCR guidance clearly explain how Covered Entities and their Business Associates may collaborate and communicate with other Covered Entities and Public Health Authorities during the COVID-19 outbreak, and how to communicate with family, friends and others involved in the patient’s care. 

    This webinar will explain how Covered Entities and Business Associates can continue to serve their patients and wider communities with patient care, and protect themselves from HIPAA violations, and what are the limited waivers if the President declares a Public Health Emergency. 

    Why you should Attend:

    You will find out how to follow HIPAA and use and disclose PHI during the COVID-19 outbreak. You will also learn how to coordinate and collaborate with Public Health Authorities, and communicate with persons at risk for contracting the disease; in situations to prevent a serious and imminent threat; and with the media and others not involved in the patient’s care. You will also learn about the limited waivers of HIPAA sanctions and penalties for hospitals in a Presidential Declaration of a Public Health Emergency.

    Areas Covered in the Session:

    • Brief review of the HIPAA Privacy Rule, HIPAA Authorization and the Minimum Necessary Standard
    • How HIPAA Rules apply in a public health emergency like an infectious disease outbreak
    • Review of the situations where patient information may be shared without an individual’s Authorization
    • Communication with family, friends and others involved in a patient’s care
    • Disclosures to prevent a serious and imminent threat
    • Disclosures to the media and others not involved in the care of the patient/notification
    • How the Minimum Necessary Standard applies
    • In the event of a Presidential Declaration, how the limited waiver of HIPAA sanctions and penalties for hospitals apply, including which hospitals may count on the waivers

  • March 14, 2020 1:22 PM | Anonymous

    brought to you by your NHADACA Ethics Committee

    The following updates related to the work of the National Academy of Medicine (NAM) Action Collaborative on Clinician Well-Being and Resilience (Clinician Well-Being Collaborative). 

    Taking Action Against Clinician Burnout Report

    The NAM released the consensus report, Taking Action Against Clinician Burnout: A Systems Approach to Professional Well-Being, in October 2019. The report calls upon leaders in health care organizations, health professions educational institutions, government, and industry to prioritize major improvements in clinical work and learning environments across all care settings, and for all disciplines to prevent and mitigate clinician burnout and foster professional well-being for the overall health of clinicians, patients, and the nation.

    Check out the related products that have been released since October:

    Research Agenda

    Health Care Leadership Brief

    Report Highlights

    Report Recommendations

    Key Messages

    Social Media Toolkit

    The NAM Clinician Well-Being Collaborative is committed to elevating the findings, conclusions, and recommendations from the report, as well as translating the report recommendations into action. We look forward to keeping you updated on these endeavors.

    Top 10 NAM Perspectives of 2019

    1.     In 2019, NAM Perspectives papers were released on a variety of topics, including reducing clinician burnout. Half of the 10 most popular titles of 2019 were products of the NAM Clinician Well-Being Collaborative! Check them out below:
    2.     Implementing Optimal Team-Based Care to Reduce Clinician Burnout
    3.     Burnout Among Health Care Professionals: A Call to Explore and Address this Underrecognized Threat to Safe, High-Quality Care
    4.     Nurse Suicide: Breaking the Silence
    5.     Gender-Based Differences in Burnout: Issues Faced by Women Physicians
    6.     Burnout and Job and Career Satisfaction in the Physician Assistant Profession: A Review of the Literature

    Visit to access additional information about all of the top 10 papers, as well as a social media kit to share these papers with your colleagues and friends. Read additional publications from the NAM Clinician Well-Being Collaborative.   

    Health Policy Institute of Ohio’s Evidence-Based Policy Brief on Clinician Well-Being and Patient Safety

    Bernadette Melnyk, Vice President for Health Promotion, University Chief Wellness Officer, and Dean & Professor of the College of Nursing at The Ohio State University, worked on an evidence-based policy brief on clinician well-being and patient safety with the Health Policy Institute of Ohio, which builds upon the work of the NAM Clinician Well-Being Collaborative. They released the brief during a successful state-wide forum at Ohio State with policymakers and health care leaders across the state of Ohio. Additionally, they are launching a state-wide action collaborative to address clinician burnout, and encourage others to form similar state-wide efforts. Access the brief and executive summary.


  • February 27, 2020 4:44 PM | Anonymous

    Medicare clients are turned away from substance use disorder treatment or are serviced for free because they can't access therapy with a counselor who is also a Medicare provider. The Medicare system has historically only accepted and reimbursed services of master’s level clinicians who are licensed social workers.   There are a large number of qualified clinical professionals with equal, or additional, qualifications to treat substance use and other co-occurring mental health disorders, that cannot bill Medicare. Medicare reimbursement policies must be modified.  There is a current bill that can solve this problem, but it needs your help to move forward.

    The "Medicare for America Act" was sent to the House in May of 2019 and then to the judiciary committee on 5/31/19. It now needs to get out of committee, get drafted to include language allowing MLADCs and LCMHCs to be reimbursed for Medicare, and sent to the Senate.  Call or write your Congressperson.

    The Addiction Treatment Access Act does make changes and is in front of the Senate, as of August of 2019. It is currently in the committee on finance. We have to see some movement.  Please call or write your senator.

    Ask them to help get these bills pushed through and support them becoming law.  

    Congresswoman Annie Kuster

    Congressman Chris Pappas

    Senator Jeanne Shaheen

    Senator Maggie Hassan

  • February 14, 2020 9:44 AM | Anonymous

    Brought to you by your NHADACA Ethics Committee

    Psychotic Symptoms in Some Marijuana Users Challenge Providers

    Today's increasingly favored delivery systems for the psychoactive compound in marijuana have heightened the risk of psychotic symptoms among users, according to leaders in the treatment and research communities. An addiction treatment center medical director tells Addiction Professional that in a growing number of cases he encounters, the effects of vaping THC or using marijuana wax have become so pronounced that the individual cannot successfully be helped in a traditional substance use treatment setting.

  • February 10, 2020 3:21 PM | Anonymous

    From Maury Elsasser...

    I hope this finds you well. As you know of my obsession with Outcome Measures and Value-based care as the future of sustainable affordable healthcare but most immediately a pathway to saving more lives in the opioid epidemic.  I’ve been extremely  lucky to have been a member of ICHOM’s Workgroup this past year developing a Standard Set of Outcome Measures for Addiction.  Well, we need your feedback for our work thus far.  I’ve copied the email below from our Research Fellow Dr. Nicola Black (she is brilliant) describing how to complete a short survey.  Please pass this on to all contacts . I really appreciate it and all the work do.  Thank you so much….Please continue to read and click the links.

    What is this work about?

    Understanding and measuring the outcomes that matter most to patients is essential for delivering value-based healthcare. To facilitate this, we have developed a proposal for a standard set of outcomes to assess following treatment for substance use and addictive behaviour disorders. Implementation of this standard set will better allow informed decision making, quality improvement, and reduced costs. We are now seeking feedback on this standard set from professionals in the field to improve this recommendation, which we hope will be a minimum global standard in clinical practice.

    What are we asking?

    We are seeking professionals to provide feedback on the proposed standard set of outcome measures via our 15-30 minute survey, by February 16, 2020. We are also seeking individuals to share this survey within their networks, either via forwarding this email, including information about the survey in any relevant newsletters, and/or retweeting it. We hope that this will be shared and completed as widely as possible, so every little bit helps.

    Who can complete the survey?

    We are seeking anyone with professional experience with substance use and/or addictive behaviour disorders (disorders related to alcohol, tobacco, other drugs, gambling, gaming, specifically). This includes researchers or educators, health or social care practitioners (e.g., clinicians, allied health professionals, social workers), government, policy or commissioning professionals, advocacy or charity professionals, commercial or industry representatives, and any other individuals with relevant professional experience. We are seeking professionals from any country. The survey is only available in English.

    Why are we seeking feedback?

    We hope that this standard set will become a minimum global standard. This can only be achieved if the set is truly fit-for-purpose in all settings. Through our working group, we have drawn on a diverse range of experiences of 26 experts in order to develop the current proposal. Now we want to expand this and draw on as many diverse perspectives as possible to ensure that we are validly and reliably capturing the outcomes that matter to people who seek treatment across all of the different populations and settings around the world.

    Who is conducting this work?

    This work is led by the International Consortium of Health Outcome Measurement (ICHOM). The project team consists of the project managers, Sophie Chung and Luz Fialho (ICHOM), the chair, Prof Michael Farrell (National Drug and Alcohol Research Centre), and the research fellow, Dr Nicola Black (National Drug and Alcohol Research Centre). All major decisions in the project have been made via consensus from an international, multidisciplinary group of 26 experts from 11 countries: Dr Apinun Aramrattana (Chiang Mai University), Prof Sawitri Assanangkornchai (Prince of Songkla University), Prof Alex Blaszczynski (University of Sydney), Dr Henrietta Bowden-Jones (Imperial College London), Adrian Brown (Central and North West London Trust), Dr Qiana Brown (Rutgers University), Dr Linda Cottler (University of Florida), Maury Elsasser*, Dr Marica Ferri (European Monitoring Centre for Drugs and Drug Addiction), Dr Maria Florence (University of the Western Cape), Dr Ralitza Gueorguieva (Yale School of Public Health), Ryan Hampton*, Dr Suzie Hudson (Network of Alcohol and other Drugs Agencies), A/Prof Peter Kelly (University of Wollongong), Prof Nicholas Lintzeris (University of Sydney), Lyn Murphy*, Dr Abhijit Nadkarni (Sangath), Prof Joanne Neale (King’s College London), Prof Daniel Rosen (University of Pittsburgh), Dr Hans-Jürgen Rumpf (Universität zu Lübeck), Dr Brian Rush (Centre for Addiction and Mental Health), Gabriel Segal* (Alcoholics Anonymous), Dr Gillian Shorter (Ulster University), Prof Marta Torrens (Universitat Autònoma de Barcelona), Prof Wim van den Brink (University of Amsterdam), Chris Wait* (Build on Belief). *Working group members with lived experience.

  • January 31, 2020 3:54 PM | Anonymous

    New Hampshire needs your voice.

    On Tuesday, February 4th, the Senate Commerce Committee will hold a public hearing on SB 621, which would allow ready to drink spirit based cocktails (products such as "Tequila Paloma" and "Rum and Cola") available in convenience and grocery stores, making these higher alcohol percentage drinks widely accessible and available. The size of these cocktails can range from a single serving size to 749 milliliters - one milliliter less than a bottle of wine! 

    Make your voice heard on why SB 621 is wrong for New Hampshire and join us at the hearing.

    Committee Hearing on SB 621

    Tuesday, February 4th at 2:30 p.m.

    State House Room 100

    107 N. Main St. Concord, NH 03301


    This policy change would be a monumental shift in New Hampshire's current regulatory system which requires liquor products like these to be sold in state run liquor stores. Polices such as this one, which regulate the percentage and location of where liquor is sold, are in place to protect public health and safety. New Hampshire is currently struggling with a substance misuse epidemic and alcohol remains the most prevalent substance misused in the United States and New Hampshire. Now is not the time to weaken New Hampshire's alcohol regulations. 


    Can't make it to the hearing? We need strong advocates to call committee members today and urge them to oppose SB 621. 


    Thank you for your continued advocacy for our Granite State communities!

  • January 28, 2020 9:16 AM | Anonymous

    Available Now!

    Download Instantly!


    A newly updated and abridged version of the Legal Action Center’s Book, Confidentiality & Communication, is now available as an eBook. It covers all the essentials for understanding confidentiality, including answers to questions like: 


    • When do 42 CFR Part 2 and HIPAA apply?
    • How did the 2017 amendments change the requirements for consent forms, patient privacy notices and the notice of prohibition on re-disclosure?
    • How to make disclosures for medical emergencies, audits, or research?
    • How can a program report a crime on program premises?
    • What should a program do if it receives a subpoena, search warrant, or arrest warrant?
    • What privacy rights do patients have?
    • How are the laws enforced and what are the security requirements?
    • What are best practices for common confidentiality issues? 


    Confidentiality & Communication is an indispensable guide to substance use disorder (SUD) privacy for new members of the SUD treatment field and stakeholders who work with individuals receiving SUD treatment, as well as seasoned confidentiality experts with questions about the 2017 and 2018 amendments to 42 CFR Part 2.

    Available for instant download for only $109. Click here to buy!


    The 2020 edition also explains the newest proposal by SAMHSA to amend the confidentiality regulations again, and flags areas where the regulations are subject to change in the future. If the regulations change in 2020, LAC will publish a new edition with fully updated information and offer a discount to customers who purchased the current edition. To see a full list of the topics covered in the abridged and updated 2020 edition of Confidentiality & Communication, visit the online Table of Contents

    The 2020 edition of Confidentiality & Communication is available as an e-book only.

  • January 09, 2020 9:53 AM | Anonymous

    Exhibitor and Sponsor Registration for the NAADAC 2020 Annual Conference & Hill Day Is Now Open!

    NAADAC, the Association for Addiction Professionals, invites you to join the family of exhibitors, sponsors, and advertisers at its 2020 Annual Conference & Hill Day: Learn, Connect, Advocate, Succeed, in Washington, DC at the Gaylord National Resort & Convention Center from September 25-30, 2020.

    Over 1,000 addiction professionals gathered in Orlando, FL for the NAADAC 2019 Annual Conference last September to hear the latest information on addiction prevention, treatment, recovery support, and education. The 2020 Annual Conference & Hill Day in Washington, DC will be even bigger and better!

    Exhibiting is an excellent opportunity to present information about your organization

    and to develop new contacts. Don't miss this chance to attend one of the largest gatherings of addiction-focused professionals of the year!

    Download 2020 Prospectus

    Exhibitor Information

    The 2020 Annual Conference & Hill Day Exhibit Hall at the Gaylord National Resort & Convention Center will be open on September 25-27, 2020. Exhibit booth rentals are 10' x 8’ in size. Special requests for other sizes will be accommodated if possible. Booths will be assigned on a first-come, first-served basis.

    In-line booth: $1,500 | Corner booth: $2,000

    All exhibitors receive two full conference registration badges and inclusion in our onsite program.

    Bundle and save through our Exhibitor Maximum Exposure Package Opportunity!

    Download 2020 Exhibit Application & Contract

    Sponsorship Opportunities

    NAADAC offers a range of custom sponsorship and advertising opportunities to maximize exposure and provide companies with exclusive chances to network with other addiction-focused health care professionals and, more importantly, with decision-makers in the addiction community.

    Get your company name, logo, and services in front of over 1,000 addiction-focused health care professionals and more than 100 exhibitors!

    Available sponsorship opportunities include: conference lanyards, hotel key cards, exclusive networking receptions, conference program ads, conference mobile app ads, promotional portfolio inserts, hotel room drops, and much more!

Sign up for a training today!

Discover professional development training events in New Hampshire & surrounding areas.

View Training Events


Stay connected with NHADACA! 

Stay Connected

Sign up to get updates, news & more!

Get in Touch

We'd love to hear from you!
130 Pembroke Road, Suite 150
Concord, NH 03301
view map
Office Hours
Monday – Friday
8AM – 4PM

Connect on Facebook

Join our facebook community! 
Powered by Wild Apricot Membership Software